18 results
Stress Ulcer Prophylaxis

Stress ulcerations are common in ICU patients and may lead to hemorrhage if not
are common in ICU ... prophylaxis for primary prevention ... ulceration or treatment ... #Prophylaxis #criticalcare ... #pharmacology #
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Recommendations for Preventing ... in HIV-AIDS Preventing ... • In rare cases ... #Treatment #management ... #HIVAIDS #pharmacology
Pain, Agitation, and Delirium (PAD) in the ICU
Addressing the ICU Triad (PAD) can be accomplished through
Agitation Sedation Scale ... it should not cause ... No pharmacologic ... #CriticalCare # ... diagnosis #management
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
↑ sIL-2R >2400 Ul ... Drugs, Unknown cause ... Treatment: • ... of emergency, ICU ... Lymphohistiocytosis #diagnosis #management
Sepsis - Diagnosis and Management
Life-threatening organ dysfunction caused by a dysregulated host response to infection
SEPTIC SHOCK
organ dysfunction caused ... host response to infection ... recognition and treatment ... #QSOFA #SIRS #criticalcare ... #icu
COVID-19 - A Seattle Intensivist's One-Page Cheat-Sheet on COVID-19 v2.7 Updated March 26 2020

(v2.7) incorporating newer
COVID19 in the ICU ... Wuhan Virus") • Infection ... unilateral* • POCUS ... Cheatsheet #Diagnosis #Management ... #Coronavirus #CriticalCare
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
the determined cause ... differential #algorithm #management ... heartfailure #chf #criticalcare ... #icu #clinical ... #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
Cytomegalovirus Infections ... in HIV-AIDS Preventing ... until steady state ... #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
for effective treatment ... mucosal #IDSA #Prevention ... #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
Recommendations for Preventing ... Pre-Exposure Prevention ... Uncomplicated Cases ... #Treatment #management ... #HIVAIDS #pharmacology